-
Something wrong with this record ?
Fertility Among Female Survivors of Childhood, Adolescent, and Young Adult Cancer: Protocol for Two Pan-European Studies (PanCareLIFE)
M. van den Berg, M. van Dijk, J. Byrne, H. Campbell, C. Berger, A. Borgmann-Staudt, G. Calaminus, U. Dirksen, JF. Winther, SD. Fossa, D. Grabow, VL. Grandage, MM. van den Heuvel-Eibrink, M. Kaiser, T. Kepak, LC. Kremer, J. Kruseova, CE. Kuehni,...
Language English Country Canada
Document type Journal Article
NLK
Directory of Open Access Journals
from 2012
Free Medical Journals
from 2012
PubMed Central
from 2012
Europe PubMed Central
from 2012
ProQuest Central
from 2012-01-01
Open Access Digital Library
from 2012-01-01
Open Access Digital Library
from 2012-01-01
Nursing & Allied Health Database (ProQuest)
from 2012-01-01
Health & Medicine (ProQuest)
from 2012-01-01
Public Health Database (ProQuest)
from 2012-01-01
ROAD: Directory of Open Access Scholarly Resources
from 2012
PubMed
30215599
DOI
10.2196/10824
Knihovny.cz E-resources
- Publication type
- Journal Article MeSH
BACKGROUND: Despite a significant number of studies on female fertility following childhood, adolescent, and young adult (CAYA) cancer, studies establishing precise (dose-related) estimates of treatment-related risks are still scarce. Previous studies have been underpowered, did not include detailed treatment information, or were based on self-report only without any hormonal assessments. More precise assessments of who is at risk for sub- or infertility are needed. OBJECTIVE: The objective of our study is to describe the design and methods of 2 studies on female fertility (a cohort study and a nested case-control study) among female survivors of CAYA cancer performed within the European PanCareLIFE project. METHODS: For the cohort study, which aims to evaluate the overall risk of fertility impairment, as well as the risk for specific subgroups of female CAYA cancer survivors, 13 institutions from 9 countries provide data on fertility impairment. Survivors are defined as being fertility impaired if they meet at least one of 8 different criteria based on self-reported and hormonal data. For the nested case-control study, which aims to identify specific treatment-related risk factors associated with fertility impairment in addition to possible dose-response relationships, cases (fertility impaired survivors) are selected from the cohort study and matched to controls (survivors without fertility impairment) on a 1:2 basis. RESULTS: Of the 10,964 survivors invited for the cohort study, data are available from 6619 survivors, either questionnaire-based only (n=4979), hormonal-based only (n=72), or both (n=1568). For the nested case-control study, a total of 450 cases and 882 controls are identified. CONCLUSIONS: Results of both PanCareLIFE fertility studies will provide detailed insight into the risk of fertility impairment following CAYA cancer and diagnostic- or treatment-related factors associated with an increased risk. This will help clinicians to adequately counsel both girls and young women, who are about to start anticancer treatment, as well as adult female CAYA cancer survivors, concerning future parenthood and to timely refer them for fertility preservation. Ultimately, we aim to empower patients and survivors and improve their quality of life. REGISTERED REPORT IDENTIFIER: RR1-10.2196/10824.
Boyne Research Institute Drogheda Ireland
Centre Hospitalier Universitaire de Saint Étienne Saint Étienne France
Department of Obstetrics and Gynaecology Amsterdam UMC Vrije Universiteit Amsterdam Netherlands
Department of Pediatrics Amsterdam UMC Vrije Universiteit Amsterdam Netherlands
Gaslini Children Hospital Genova Italy
Great Ormond Street Children's Hospital London United Kingdom
International Clinical Research Center of St Anne's University Hospital Brno Brno Czech Republic
Motol Teaching Hospital Prague Czech Republic
Netherlands Cancer Institute Amsterdam Netherlands
Oslo University Hospital Oslo Norway
Swiss Childhood Cancer Registry University of Bern Bern Switzerland
University Children's Hospital Bonn University of Bonn Medical School Bonn Germany
References provided by Crossref.org
- 000
- 00000naa a2200000 a 4500
- 001
- bmc18034189
- 003
- CZ-PrNML
- 005
- 20181024170906.0
- 007
- ta
- 008
- 181008s2018 xxc f 000 0|eng||
- 009
- AR
- 024 7_
- $a 10.2196/10824 $2 doi
- 035 __
- $a (PubMed)30215599
- 040 __
- $a ABA008 $b cze $d ABA008 $e AACR2
- 041 0_
- $a eng
- 044 __
- $a xxc
- 100 1_
- $a van den Berg, Marleen $u Department of Pediatrics, Amsterdam UMC, Vrije Universiteit, Amsterdam, Netherlands.
- 245 10
- $a Fertility Among Female Survivors of Childhood, Adolescent, and Young Adult Cancer: Protocol for Two Pan-European Studies (PanCareLIFE) / $c M. van den Berg, M. van Dijk, J. Byrne, H. Campbell, C. Berger, A. Borgmann-Staudt, G. Calaminus, U. Dirksen, JF. Winther, SD. Fossa, D. Grabow, VL. Grandage, MM. van den Heuvel-Eibrink, M. Kaiser, T. Kepak, LC. Kremer, J. Kruseova, CE. Kuehni, CB. Lambalk, FE. van Leeuwen, A. Leiper, D. Modan-Moses, V. Morsellino, C. Spix, P. Kaatsch, E. van Dulmen-den Broeder, . ,
- 520 9_
- $a BACKGROUND: Despite a significant number of studies on female fertility following childhood, adolescent, and young adult (CAYA) cancer, studies establishing precise (dose-related) estimates of treatment-related risks are still scarce. Previous studies have been underpowered, did not include detailed treatment information, or were based on self-report only without any hormonal assessments. More precise assessments of who is at risk for sub- or infertility are needed. OBJECTIVE: The objective of our study is to describe the design and methods of 2 studies on female fertility (a cohort study and a nested case-control study) among female survivors of CAYA cancer performed within the European PanCareLIFE project. METHODS: For the cohort study, which aims to evaluate the overall risk of fertility impairment, as well as the risk for specific subgroups of female CAYA cancer survivors, 13 institutions from 9 countries provide data on fertility impairment. Survivors are defined as being fertility impaired if they meet at least one of 8 different criteria based on self-reported and hormonal data. For the nested case-control study, which aims to identify specific treatment-related risk factors associated with fertility impairment in addition to possible dose-response relationships, cases (fertility impaired survivors) are selected from the cohort study and matched to controls (survivors without fertility impairment) on a 1:2 basis. RESULTS: Of the 10,964 survivors invited for the cohort study, data are available from 6619 survivors, either questionnaire-based only (n=4979), hormonal-based only (n=72), or both (n=1568). For the nested case-control study, a total of 450 cases and 882 controls are identified. CONCLUSIONS: Results of both PanCareLIFE fertility studies will provide detailed insight into the risk of fertility impairment following CAYA cancer and diagnostic- or treatment-related factors associated with an increased risk. This will help clinicians to adequately counsel both girls and young women, who are about to start anticancer treatment, as well as adult female CAYA cancer survivors, concerning future parenthood and to timely refer them for fertility preservation. Ultimately, we aim to empower patients and survivors and improve their quality of life. REGISTERED REPORT IDENTIFIER: RR1-10.2196/10824.
- 655 _2
- $a časopisecké články $7 D016428
- 700 1_
- $a van Dijk, Marloes $u Department of Pediatrics, Amsterdam UMC, Vrije Universiteit, Amsterdam, Netherlands.
- 700 1_
- $a Byrne, Julianne $u Boyne Research Institute, Drogheda, Ireland.
- 700 1_
- $a Campbell, Helen $u Boyne Research Institute, Drogheda, Ireland.
- 700 1_
- $a Berger, Claire $u Centre Hospitalier Universitaire de Saint-Étienne, Saint-Étienne, France.
- 700 1_
- $a Borgmann-Staudt, Anja $u Division of Oncology and Hematology, Department of Pediatrics, Charité - Universitätsmedizin Berlin, Berlin, Germany.
- 700 1_
- $a Calaminus, Gabriele $u University Children's Hospital Bonn, University of Bonn Medical School, Bonn, Germany.
- 700 1_
- $a Dirksen, Uta $u Pediatrics III, University Hospital Essen, Essen, Germany. West German Cancer Centre, German Cancer Research Centre, Essen, Germany.
- 700 1_
- $a Winther, Jeanette F $u Danish Cancer Society Research Center, Copenhagen, Denmark. Department of Clinical Medicine, Faculty of Health, Aarhus University Hospital, Aarhus, Denmark.
- 700 1_
- $a Fossa, Sophie D $u Oslo University Hospital, Oslo, Norway.
- 700 1_
- $a Grabow, Desiree $u German Childhood Cancer Registry, Institute for Medical Biometry, Epidemiology and Informatics, University Medical Center Mainz, Mainz, Germany.
- 700 1_
- $a Grandage, Victoria L $u University College London Hospital, London, United Kingdom.
- 700 1_
- $a van den Heuvel-Eibrink, Marry M $u Princess Máxima Center for Pediatric Oncology, Utrecht, Netherlands. Erasmus MC University Medical Center, Rotterdam, Netherlands.
- 700 1_
- $a Kaiser, Melanie $u German Childhood Cancer Registry, Institute for Medical Biometry, Epidemiology and Informatics, University Medical Center Mainz, Mainz, Germany.
- 700 1_
- $a Kepak, Tomas $u International Clinical Research Center of St Anne's University Hospital Brno, Brno, Czech Republic.
- 700 1_
- $a Kremer, Leontien C $u Princess Máxima Center for Pediatric Oncology, Utrecht, Netherlands. Department of Pediatrics, Amsterdam UMC, University of Amsterdam, Amsterdam, Netherlands.
- 700 1_
- $a Kruseova, Jarmila $u Motol Teaching Hospital, Prague, Czech Republic.
- 700 1_
- $a Kuehni, Claudia E $u Swiss Childhood Cancer Registry, University of Bern, Bern, Switzerland.
- 700 1_
- $a Lambalk, Cornelis B $u Department of Obstetrics and Gynaecology, Amsterdam UMC, Vrije Universiteit, Amsterdam, Netherlands.
- 700 1_
- $a van Leeuwen, Flora E $u Netherlands Cancer Institute, Amsterdam, Netherlands.
- 700 1_
- $a Leiper, Alison $u Great Ormond Street Children's Hospital, London, United Kingdom.
- 700 1_
- $a Modan-Moses, Dalit $u Edmond and Lily Safra Children's Hospital, Chaim Sheba Medical Center, Tel-Aviv, Israel. The Sackler Faculty of Medicine, Tel-Aviv University, Tel-Aviv, Israel.
- 700 1_
- $a Morsellino, Vera $u Gaslini Children Hospital, Genova, Italy.
- 700 1_
- $a Spix, Claudia $u German Childhood Cancer Registry, Institute for Medical Biometry, Epidemiology and Informatics, University Medical Center Mainz, Mainz, Germany.
- 700 1_
- $a Kaatsch, Peter $u German Childhood Cancer Registry, Institute for Medical Biometry, Epidemiology and Informatics, University Medical Center Mainz, Mainz, Germany.
- 700 1_
- $a van Dulmen-den Broeder, Eline $u Department of Pediatrics, Amsterdam UMC, Vrije Universiteit, Amsterdam, Netherlands.
- 700 1_
- $a ,
- 773 0_
- $w MED00193519 $t JMIR research protocols $x 1929-0748 $g Roč. 7, č. 9 (2018), s. e10824
- 856 41
- $u https://pubmed.ncbi.nlm.nih.gov/30215599 $y Pubmed
- 910 __
- $a ABA008 $b sig $c sign $y a $z 0
- 990 __
- $a 20181008 $b ABA008
- 991 __
- $a 20181024171415 $b ABA008
- 999 __
- $a ind $b bmc $g 1341063 $s 1031183
- BAS __
- $a 3
- BAS __
- $a PreBMC
- BMC __
- $a 2018 $b 7 $c 9 $d e10824 $e 20180914 $i 1929-0748 $m JMIR research protocols $n JMIR Res Protoc $x MED00193519
- LZP __
- $a Pubmed-20181008
